New

Intravenous Immunoglobulin Market

2021

Intravenous Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Hypogammaglobulinemia, CIPD, Immunodeficiency diseases, Congenital AIDS, Chronic Lymphocytic Leukemia, Myasthenia Gravis, Multifocal motor neuropathy, ITP, Kawasaki disease, Guillain-Barre syndrome and Others); Type (IgG, IgA, IgM, IgE, IgD) and Geography

| Report Code: TIPRE00004079 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Intravenous Immunoglobulin Market 2028 By Application, Type and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to foreign antigens. They are quite complex and act in a very specific manner. They are obtained from blood through fractionation process and then purified for various therapeutic and nontherapeutic uses. Immunoglobulins of various classes, such as IgG, IgA, and IgM, are utilised to treat a variety of immunological and neurological disorders.

MARKET SCOPE



The "Global Intravenous Immunoglobulin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the intravenous immunoglobulin market with detailed market segmentation by application and type. The report provides key statistics on the market status of the leading intravenous immunoglobulin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on application the market is segmented as, hypogammaglobulinemia, CIPD, immunodeficiency diseases, congenital AIDS, chronic lymphocytic leukemia, myasthenia gravis, multifocal motor neuropathy, ITP, kawasaki disease, guillain-barre syndrome and others.
  • Based on type the market is segmented as, IGG, IGA, IGM, IGE and IGD.

MARKET DYNAMICS


Drivers:



  • Increasing number of hemophillic patients along with rising geriatric population.
  • Advancements in technologies for immunoglobulin production and purification.
  • Growing prevalence of diseases such as, hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy.
  • Extensive R&D efforts for developing immunoglobulin therapies for management of chronic as well ass idiosyncratic diseases.

Restraints:



  • However, risk of side effects associated with the adoption intravenous immunoglobulins are likely to restrain market growth.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The intravenous immunoglobulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the intravenous immunoglobulin market in these regions.

IMPACT OF COVID-19 ON INTRAVENOUS IMMUNOGLOBULIN MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the intravenous immunoglobulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from intravenous immunoglobulin market are anticipated to lucrative growth opportunities in the future with the rising demand for intravenous immunoglobulin in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the intravenous immunoglobulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Biotest AG
  • Octapharma AG
  • ADMA Biologics, Inc.
  • LFB group
  • Shanghai RAAS
  • Grifols, S.A
  • Kedrion S.p.A
  • CSL
  • Pfizer Inc
  • Takeda Pharmaceutical Company Limited
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Intravenous Immunoglobulin Market - By Application
    1.3.2 Intravenous Immunoglobulin Market - By Type
    1.3.3 Intravenous Immunoglobulin Market - By Region
    1.3.3.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. INTRAVENOUS IMMUNOGLOBULIN MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. INTRAVENOUS IMMUNOGLOBULIN MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. INTRAVENOUS IMMUNOGLOBULIN MARKET - GLOBAL MARKET ANALYSIS
    6.1. INTRAVENOUS IMMUNOGLOBULIN - GLOBAL MARKET OVERVIEW
    6.2. INTRAVENOUS IMMUNOGLOBULIN - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. INTRAVENOUS IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
    7.1. OVERVIEW
    7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
    7.3. HYPOGAMMAGLOBULINEMIA
    7.3.1. Overview
    7.3.2. Hypogammaglobulinemia Market Forecast and Analysis
    7.4. CIPD
    7.4.1. Overview
    7.4.2. CIPD Market Forecast and Analysis
    7.5. IMMUNODEFICIENCY DISEASES
    7.5.1. Overview
    7.5.2. Immunodeficiency diseases Market Forecast and Analysis
    7.6. CONGENITAL AIDS
    7.6.1. Overview
    7.6.2. Congenital AIDS Market Forecast and Analysis
    7.7. CHRONIC LYMPHOCYTIC LEUKEMIA
    7.7.1. Overview
    7.7.2. Chronic Lymphocytic Leukemia Market Forecast and Analysis
    7.8. MYASTHENIA GRAVIS
    7.8.1. Overview
    7.8.2. Myasthenia Gravis Market Forecast and Analysis
    7.9. MULTIFOCAL MOTOR NEUROPATHY
    7.9.1. Overview
    7.9.2. Multifocal motor neuropathy Market Forecast and Analysis
    7.10. ITP
    7.10.1. Overview
    7.10.2. ITP Market Forecast and Analysis
    7.11. KAWASAKI DISEASE
    7.11.1. Overview
    7.11.2. Kawasaki disease Market Forecast and Analysis
    7.12. GUILLAIN-BARRE SYNDROME AND OTHERS
    7.12.1. Overview
    7.12.2. Guillain-Barre syndrome and Others Market Forecast and Analysis
    8. INTRAVENOUS IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
    8.1. OVERVIEW
    8.2. TYPE MARKET FORECASTS AND ANALYSIS
    8.3. IGG
    8.3.1. Overview
    8.3.2. IgG Market Forecast and Analysis
    8.4. IGA
    8.4.1. Overview
    8.4.2. IgA Market Forecast and Analysis
    8.5. IGM
    8.5.1. Overview
    8.5.2. IgM Market Forecast and Analysis
    8.6. IGE
    8.6.1. Overview
    8.6.2. IgE Market Forecast and Analysis
    8.7. IGD
    8.7.1. Overview
    8.7.2. IgD Market Forecast and Analysis

    9. INTRAVENOUS IMMUNOGLOBULIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    9.1. NORTH AMERICA
    9.1.1 North America Intravenous Immunoglobulin Market Overview
    9.1.2 North America Intravenous Immunoglobulin Market Forecasts and Analysis
    9.1.3 North America Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
    9.1.4 North America Intravenous Immunoglobulin Market Forecasts and Analysis - By Type
    9.1.5 North America Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
    9.1.5.1 United States Intravenous Immunoglobulin Market
    9.1.5.1.1 United States Intravenous Immunoglobulin Market by Application
    9.1.5.1.2 United States Intravenous Immunoglobulin Market by Type
    9.1.5.2 Canada Intravenous Immunoglobulin Market
    9.1.5.2.1 Canada Intravenous Immunoglobulin Market by Application
    9.1.5.2.2 Canada Intravenous Immunoglobulin Market by Type
    9.1.5.3 Mexico Intravenous Immunoglobulin Market
    9.1.5.3.1 Mexico Intravenous Immunoglobulin Market by Application
    9.1.5.3.2 Mexico Intravenous Immunoglobulin Market by Type
    9.2. EUROPE
    9.2.1 Europe Intravenous Immunoglobulin Market Overview
    9.2.2 Europe Intravenous Immunoglobulin Market Forecasts and Analysis
    9.2.3 Europe Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
    9.2.4 Europe Intravenous Immunoglobulin Market Forecasts and Analysis - By Type
    9.2.5 Europe Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
    9.2.5.1 Germany Intravenous Immunoglobulin Market
    9.2.5.1.1 Germany Intravenous Immunoglobulin Market by Application
    9.2.5.1.2 Germany Intravenous Immunoglobulin Market by Type
    9.2.5.2 France Intravenous Immunoglobulin Market
    9.2.5.2.1 France Intravenous Immunoglobulin Market by Application
    9.2.5.2.2 France Intravenous Immunoglobulin Market by Type
    9.2.5.3 Italy Intravenous Immunoglobulin Market
    9.2.5.3.1 Italy Intravenous Immunoglobulin Market by Application
    9.2.5.3.2 Italy Intravenous Immunoglobulin Market by Type
    9.2.5.4 Spain Intravenous Immunoglobulin Market
    9.2.5.4.1 Spain Intravenous Immunoglobulin Market by Application
    9.2.5.4.2 Spain Intravenous Immunoglobulin Market by Type
    9.2.5.5 United Kingdom Intravenous Immunoglobulin Market
    9.2.5.5.1 United Kingdom Intravenous Immunoglobulin Market by Application
    9.2.5.5.2 United Kingdom Intravenous Immunoglobulin Market by Type
    9.2.5.6 Rest of Europe Intravenous Immunoglobulin Market
    9.2.5.6.1 Rest of Europe Intravenous Immunoglobulin Market by Application
    9.2.5.6.2 Rest of Europe Intravenous Immunoglobulin Market by Type
    9.3. ASIA-PACIFIC
    9.3.1 Asia-Pacific Intravenous Immunoglobulin Market Overview
    9.3.2 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis
    9.3.3 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
    9.3.4 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis - By Type
    9.3.5 Asia-Pacific Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
    9.3.5.1 Australia Intravenous Immunoglobulin Market
    9.3.5.1.1 Australia Intravenous Immunoglobulin Market by Application
    9.3.5.1.2 Australia Intravenous Immunoglobulin Market by Type
    9.3.5.2 China Intravenous Immunoglobulin Market
    9.3.5.2.1 China Intravenous Immunoglobulin Market by Application
    9.3.5.2.2 China Intravenous Immunoglobulin Market by Type
    9.3.5.3 India Intravenous Immunoglobulin Market
    9.3.5.3.1 India Intravenous Immunoglobulin Market by Application
    9.3.5.3.2 India Intravenous Immunoglobulin Market by Type
    9.3.5.4 Japan Intravenous Immunoglobulin Market
    9.3.5.4.1 Japan Intravenous Immunoglobulin Market by Application
    9.3.5.4.2 Japan Intravenous Immunoglobulin Market by Type
    9.3.5.5 South Korea Intravenous Immunoglobulin Market
    9.3.5.5.1 South Korea Intravenous Immunoglobulin Market by Application
    9.3.5.5.2 South Korea Intravenous Immunoglobulin Market by Type
    9.3.5.6 Rest of Asia-Pacific Intravenous Immunoglobulin Market
    9.3.5.6.1 Rest of Asia-Pacific Intravenous Immunoglobulin Market by Application
    9.3.5.6.2 Rest of Asia-Pacific Intravenous Immunoglobulin Market by Type
    9.4. MIDDLE EAST AND AFRICA
    9.4.1 Middle East and Africa Intravenous Immunoglobulin Market Overview
    9.4.2 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis
    9.4.3 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
    9.4.4 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis - By Type
    9.4.5 Middle East and Africa Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
    9.4.5.1 South Africa Intravenous Immunoglobulin Market
    9.4.5.1.1 South Africa Intravenous Immunoglobulin Market by Application
    9.4.5.1.2 South Africa Intravenous Immunoglobulin Market by Type
    9.4.5.2 Saudi Arabia Intravenous Immunoglobulin Market
    9.4.5.2.1 Saudi Arabia Intravenous Immunoglobulin Market by Application
    9.4.5.2.2 Saudi Arabia Intravenous Immunoglobulin Market by Type
    9.4.5.3 U.A.E Intravenous Immunoglobulin Market
    9.4.5.3.1 U.A.E Intravenous Immunoglobulin Market by Application
    9.4.5.3.2 U.A.E Intravenous Immunoglobulin Market by Type
    9.4.5.4 Rest of Middle East and Africa Intravenous Immunoglobulin Market
    9.4.5.4.1 Rest of Middle East and Africa Intravenous Immunoglobulin Market by Application
    9.4.5.4.2 Rest of Middle East and Africa Intravenous Immunoglobulin Market by Type
    9.5. SOUTH AND CENTRAL AMERICA
    9.5.1 South and Central America Intravenous Immunoglobulin Market Overview
    9.5.2 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis
    9.5.3 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis - By Application
    9.5.4 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis - By Type
    9.5.5 South and Central America Intravenous Immunoglobulin Market Forecasts and Analysis - By Countries
    9.5.5.1 Brazil Intravenous Immunoglobulin Market
    9.5.5.1.1 Brazil Intravenous Immunoglobulin Market by Application
    9.5.5.1.2 Brazil Intravenous Immunoglobulin Market by Type
    9.5.5.2 Argentina Intravenous Immunoglobulin Market
    9.5.5.2.1 Argentina Intravenous Immunoglobulin Market by Application
    9.5.5.2.2 Argentina Intravenous Immunoglobulin Market by Type
    9.5.5.3 Rest of South and Central America Intravenous Immunoglobulin Market
    9.5.5.3.1 Rest of South and Central America Intravenous Immunoglobulin Market by Application
    9.5.5.3.2 Rest of South and Central America Intravenous Immunoglobulin Market by Type

    10. INDUSTRY LANDSCAPE
    10.1. MERGERS AND ACQUISITIONS
    10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    10.3. NEW PRODUCT LAUNCHES
    10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    11. INTRAVENOUS IMMUNOGLOBULIN MARKET, KEY COMPANY PROFILES
    11.1. BIOTEST AG
    11.1.1. Key Facts
    11.1.2. Business Description
    11.1.3. Products and Services
    11.1.4. Financial Overview
    11.1.5. SWOT Analysis
    11.1.6. Key Developments
    11.2. OCTAPHARMA AG
    11.2.1. Key Facts
    11.2.2. Business Description
    11.2.3. Products and Services
    11.2.4. Financial Overview
    11.2.5. SWOT Analysis
    11.2.6. Key Developments
    11.3. ADMA BIOLOGICS, INC.
    11.3.1. Key Facts
    11.3.2. Business Description
    11.3.3. Products and Services
    11.3.4. Financial Overview
    11.3.5. SWOT Analysis
    11.3.6. Key Developments
    11.4. LFB GROUP
    11.4.1. Key Facts
    11.4.2. Business Description
    11.4.3. Products and Services
    11.4.4. Financial Overview
    11.4.5. SWOT Analysis
    11.4.6. Key Developments
    11.5. SHANGHAI RAAS
    11.5.1. Key Facts
    11.5.2. Business Description
    11.5.3. Products and Services
    11.5.4. Financial Overview
    11.5.5. SWOT Analysis
    11.5.6. Key Developments
    11.6. GRIFOLS, S.A
    11.6.1. Key Facts
    11.6.2. Business Description
    11.6.3. Products and Services
    11.6.4. Financial Overview
    11.6.5. SWOT Analysis
    11.6.6. Key Developments
    11.7. KEDRION S.P.A
    11.7.1. Key Facts
    11.7.2. Business Description
    11.7.3. Products and Services
    11.7.4. Financial Overview
    11.7.5. SWOT Analysis
    11.7.6. Key Developments
    11.8. CSL
    11.8.1. Key Facts
    11.8.2. Business Description
    11.8.3. Products and Services
    11.8.4. Financial Overview
    11.8.5. SWOT Analysis
    11.8.6. Key Developments
    11.9. PFIZER INC
    11.9.1. Key Facts
    11.9.2. Business Description
    11.9.3. Products and Services
    11.9.4. Financial Overview
    11.9.5. SWOT Analysis
    11.9.6. Key Developments
    11.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
    11.10.1. Key Facts
    11.10.2. Business Description
    11.10.3. Products and Services
    11.10.4. Financial Overview
    11.10.5. SWOT Analysis
    11.10.6. Key Developments

    12. APPENDIX
    12.1. ABOUT THE INSIGHT PARTNERS
    12.2. GLOSSARY OF TERMS
    The List of Companies

    - Biotest AG
    - Octapharma AG
    - ADMA Biologics, Inc.
    - LFB group
    - Shanghai RAAS
    - Grifols, S.A
    - Kedrion S.p.A
    - CSL
    - Pfizer Inc
    - Takeda Pharmaceutical Company Limited
    - Abeona Therapeutics Inc
    - sanofi-aventis U.S. LLC
    TIPRE00004079
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.